Tumor-associated macrophages promote human hepatoma Huh-7 cell migration and invasion through the Gli2/IGF-II/ERK1/2 axis by secreting TGF-β1

References

• Cancer Genome Atlas Research Network. Electronic address wbe, cancer genome atlas research N. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327–1341e1323. doi:10.1016/j.cell.2017.05.046.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. 2012. Hepatocellular carcinoma. Lancet. 379(9822):1245–1255. doi:10.1016/S0140-6736(11)61347-0.
   PubMed Web of Science ®Google Scholar
• Kulik L, El-Serag HB. 2019. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 156(2):477–491 e471. doi:10.1053/j.gastro.2018.08.065.
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. 2014. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 63(5):844–855. doi:10.1136/gutjnl-2013-306627.
   PubMed Web of Science ®Google Scholar
• Ruiz I Altaba A, Sanchez P, Dahmane N. 2002. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2(5):361–372. doi:10.1038/nrc796.
   PubMed Web of Science ®Google Scholar
• Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, Mauviel A. 2011. TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res. 71(17):5606–5610. doi:10.1158/0008-5472.CAN-11-1194.
   PubMed Web of Science ®Google Scholar
• Thiyagarajan S, Bhatia N, Reagan-Shaw S, Cozma D, Thomas-Tikhonenko A, Ahmad N, Spiegelman VS. 2007. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res. 67(22):10642–10646. doi:10.1158/0008-5472.CAN-07-2015.
   PubMed Web of Science ®Google Scholar
• Narita S, So A, Ettinger S, Hayashi N, Muramaki M, Fazli L, Kim Y, Gleave ME. 2008. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin Cancer Res. 14(18):5769–5777. doi:10.1158/1078-0432.CCR-07-4282.
   PubMed Web of Science ®Google Scholar
• Zhang D, Cao L, Li Y, Lu H, Yang X, Xue P. 2013. Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy. World J Surg Oncol. 11:25. doi:10.1186/1477-7819-11-25.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23(11):549–555. doi:10.1016/S1471-4906(02)02302-5.
   PubMed Web of Science ®Google Scholar
• Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W, Welling TH. 2014. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. 147(6):1393–1404. doi:10.1053/j.gastro.2014.08.039.
   PubMed Web of Science ®Google Scholar
• Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH, et al. 2014. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 352(2):160–168. DOI:10.1016/j.canlet.2014.05.008.
   PubMed Web of Science ®Google Scholar
• Gupta DK, Singh N, Sahu DK. 2014. TGF-beta mediated crosstalk between malignant hepatocyte and tumor microenvironment in hepatocellular carcinoma. Cancer Growth Metast. 7:1–8. doi:10.4137/CGM.S14205.
   PubMedGoogle Scholar
• Perrot CY, Gilbert C, Marsaud V, Postigo A, Javelaud D, Mauviel A. 2013. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells. Pigment Cell Melanoma Res. 26(6):861–873. doi:10.1111/pcmr.12149.
   PubMed Web of Science ®Google Scholar
• Tian B, Zhao Y, Liang T, Ye X, Li Z, Yan D, Fu Q, Li Y. 2017. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway. J Drug Target. 25(7):626–636. doi:10.1080/1061186X.2017.1306535.
   PubMed Web of Science ®Google Scholar
• Yao X, Hu JF, Daniels M, Shiran H, Zhou X, Yan H, Lu H, Zeng Z, Wang Q, Li T, et al. 2003. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest. 111(2):265–273. DOI:10.1172/JCI15109.
   PubMed Web of Science ®Google Scholar
• Tai BJ, Yao M, Zheng WJ, Shen YC, Wang L, Sun JY, Wu MN, Dong ZZ, Yao DF. 2019. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation. Hbpd Int. 18(2):158–163. doi:10.1016/j.hbpd.2019.01.003.
   Google Scholar
• Brouwer-Visser J, Huang GS. 2015. IGF2 signaling and regulation in cancer. Cytokine Growth Factor Rev. 26(3):371–377. doi:10.1016/j.cytogfr.2015.01.002.
   PubMed Web of Science ®Google Scholar
• Huang R, Wang S, Wang N, Zheng Y, Zhou J, Yang B, Wang X, Zhang J, Guo L, Wang S, et al. 2020. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling. Cell Death Dis. 11(4):234. DOI:10.1038/s41419-020-2435-y.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Y. 2017. Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol. 10:58. doi:10.1186/s13045-017-0430-2.
   PubMed Web of Science ®Google Scholar
• Tao YSG, Zhu Q, Dai D, Li N, Wang H, Chen X, Hou D, Wang Y, Pan Q, Xu J, et al. 2019. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun. 10:4353. doi:10.1038/s41467-019-12384-2.
   PubMed Web of Science ®Google Scholar
• Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. 2015. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 15:577. doi:10.1186/s12885-015-1546-9.
   PubMed Web of Science ®Google Scholar
• Malik R, Lelkes PI, Cukierman E. 2015. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. 33(4):230–236. doi:10.1016/j.tibtech.2015.01.004.
   PubMed Web of Science ®Google Scholar
• Ji S, Qin Y, Shi S, Liu X, Hu H, Zhou H, Gao J, Zhang B, Xu W, Liu J, et al. 2015. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. Cell Res. 25(5):561–573. DOI:10.1038/cr.2015.30.
   PubMed Web of Science ®Google Scholar
• Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X, et al. 2017. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 66(1):157–167. DOI:10.1136/gutjnl-2015-310514.
   PubMed Web of Science ®Google Scholar
• Komohara Y, Jinushi M, Takeya M. 2014. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 105(1):1–8. doi:10.1111/cas.12314.
   PubMed Web of Science ®Google Scholar
• Chen F, Mo J, Zhang L. 2016. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription. Tumour Biol. 37(10):13403–13412. doi:10.1007/s13277-016-5256-y.
   PubMedGoogle Scholar
• Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA. 2016. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Mol Carcinog. 55(5):537–551. doi:10.1002/mc.22300.
   PubMed Web of Science ®Google Scholar
• Dennler S, André J, Alexaki I, Li A, Magnaldo T, Ten Dijke P, Wang XJ, Verrecchia F, Mauviel A. 2007. Induction of sonic hedgehog mediators by transforming growth factor-beta: smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67(14):6981–6986. doi:10.1158/0008-5472.CAN-07-0491.
   PubMed Web of Science ®Google Scholar
• Shao JB, Gao ZM, Huang WY, Lu ZB. 2017. The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells. Int J Oncol. 50(5):1623–1633. doi:10.3892/ijo.2017.3954.
   PubMed Web of Science ®Google Scholar
• Gan L, Qiu Z, Huang J, Li Y, Huang H, Xiang T, Wan J, Hui T, Lin Y, Li H, et al. 2016. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway. Int J Biol Sci. 12(12):1533–1543. DOI:10.7150/ijbs.15943.
   PubMed Web of Science ®Google Scholar
• Liu CY, Xu JY, Shi XY, Huang W, Ruan TY, Xie P, Ding JL. 2013. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest. 93(7):844–854. doi:10.1038/labinvest.2013.69.
   PubMed Web of Science ®Google Scholar
• Diaz LE, Chuan YC, Lewitt M, Fernandez-Perez L, Carrasco-Rodriguez S, Sanchez-Gomez M, Flores-Morales A. 2007. IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor. Mol Hum Reprod. 13(8):567–576. doi:10.1093/molehr/gam039.
   PubMed Web of Science ®Google Scholar
• Moorehead RA, Sanchez OH, Baldwin RM, Khokha R. 2003. Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene. 22(6):853–857. doi:10.1038/sj.onc.1206188.
   PubMed Web of Science ®Google Scholar
• Montagut C, Settleman J. 2009. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 283(2):125–134. doi:10.1016/j.canlet.2009.01.022.
   PubMed Web of Science ®Google Scholar
• Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, et al. 2013. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett. 337(2):226–236. DOI:10.1016/j.canlet.2013.05.007.
   PubMed Web of Science ®Google Scholar